Your Article Summary
See Latest ArticlesLess weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients—The PREDICTIVE BMI clinical trial
Diabetic Medicine, 08/20/08
Montanana C et al. - PREDICTIVE BMI was the first study to examine the effect of once-daily detemir with weight as the primary endpoint in a large population of overweight Type 2 diabetes patients. Use of once-daily detemir for intensification of insulin therapy resulted in less weight gain, less hypoglycaemia and equivalent glycaemic control compared with NPH.
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Circulating vaspin is unrelated to insulin sensitivity in a cohort of non-diabetic humans
European Journal of Endocrinology, 12/14/09
Plasma Total Homocysteine Levels and Methylenetetrahydrofolate Reductase Gene Polymorphism in Patients with Type 2 Diabetes Mellitus
Pathophysiology of Haemostasis and Thrombosis, 12/14/09
Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients
Clinical and Investigative Medicine, 12/14/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/14/09
Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/14/09
The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs
Current Opinion in Lipidology, 12/14/09